Meta Ads Compliance for Compounding Pharmacies, Explained

What Meta's policies actually restrict

Meta publishes its Advertising Standards openly. ¹ Two sections matter most for a compounding pharmacy. The first restricts ads that promote the sale or use of prescription drugs: that category is gated, and in most cases requires prior written permission from Meta and often a recognized certification. ¹ The second governs personal health and misleading claims, which is why exaggerated before-and-after framing and outcome promises get flagged. ¹

Restricted content (Meta)

A category of ad content that Meta allows only under specific conditions, such as prior authorization, certification, or audience limits. Prescription-drug promotion sits in this category. ¹

The practical reading: an ad that names a specific compounded drug, shows pricing, or implies you can sell a prescription product to a consumer is far more likely to be rejected than an ad that teaches a concept or speaks to a professional audience. Rules change, so treat the live policy page as the source of truth. ¹

The education and business-to-business lane

Many compounding pharmacies focus their paid social on two safer footings: educating the public about a category of care in general terms, and reaching clinicians (the prescribers and clinics they work with) rather than patients. The goal is to inform and to build professional relationships, not to push a product a consumer can buy on the spot.

• Teach a concept in general terms instead of naming a specific compounded drug.
• Speak to clinicians and clinics, not directly to patients shopping for a medication.
• Skip pricing, discounts, and "order now" framing for prescription items.
• Avoid outcome promises, dramatic transformations, and personal-attribute targeting language.
• Point to a resource (a guide, an overview, a consultation request) rather than a checkout.

Why your landing page gets reviewed too

A common surprise: the ad copy can be clean and the campaign still gets rejected because of the destination page. Meta states that ads must not lead to non-functional or policy-violating landing pages, and its review can consider the page the ad points to. ² If the ad talks education but the page sells a named prescription product with pricing, the mismatch is a problem.

So the page and the ad have to tell the same story. If the lane is education or business-to-business, the landing page should read like education or a professional resource, with claims that match what the ad implies and nothing the ad would not be allowed to say directly.

Common rejection triggers

• Naming a specific compounded drug or implying direct sale of a prescription product. ¹
• Pricing, discounts, or urgency tied to a prescription item. ¹
• Outcome promises or implied results ("lose X", "fix Y"). ¹
• Before-and-after imagery or content that focuses on an idealized body. ¹
• Copy that implies knowledge of a personal health condition (a personal-attributes problem). ¹
• A landing page that violates policy or does not match the ad. ²

Where the FTC fits in

Platform rules are only one layer. The Federal Trade Commission expects health-related advertising claims to be truthful and substantiated, and it enforces against deceptive marketing across channels, including social media. ³ In other words, even an ad that clears Meta's automated review still has to be honest and supportable under federal advertising law. The safest posture is education that you can stand behind, reviewed by counsel where claims are involved. ³

None of this is legal advice. Policies and enforcement priorities change. Verify the current Meta Advertising Standards, confirm any certification or authorization requirements that apply to you, and run claims past qualified counsel before launching. ¹²³